Exercise-Based Cardiac Rehabilitation and Improvements in Cardiorespiratory Fitness: Implications Regarding Patient Benefit Barry A. Franklin, PhD Mayo.

Slides:

Advertisements

Similar presentations

Date of download: 5/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Aspirin for the Prevention of Cardiovascular Events.

Advertisements

Date of download: 6/23/2016 From: Screening for, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the U.S. Preventive.

Copyright © 2011 American Medical Association. All rights reserved.

L-Carnitine in the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis James J. DiNicolantonio, PharmD, Carl J. Lavie,

Managing Cancer Pain: Basic Principles and Invasive Treatments

Lipoprotein(a), Cardiovascular Disease, and Contemporary Management

Contemporary Diagnosis and Management of Unstable Angina

R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R

Use of the Coronary Artery Calcium Score in Discussion of Initiation of Statin Therapy in Primary Prevention Erin D. Michos, MD, MHS, Michael J. Blaha,

James H. O’Keefe, MD, Salman K. Bhatti, MD, Ata Bajwa, MD, James J

Congestive Heart Failure in Elderly Patients

Robert M. Jacobson, MD, George J. Isham, MD, MS, Lila J

Brian Radbill, MD, Barbara Murphy, MD, Derek LeRoith, MD, PhD

Joerg Herrmann, MD, Amir Lerman, MD, Nicole P

Innovative Informatics Approaches for Peripheral Artery Disease: Current State and Provider Survey of Strategies for Improving Guideline-Based Care Alisha.

Shireen Mirza, MBBS, Roberto Benzo, MD Mayo Clinic Proceedings

Sumana Narasimhan, MD, Ruth S. Weinstock, MD, PhD

Step Care Therapy for Hypertension in Diabetic Patients

Sudden Cardiac Death From the Perspective of Coronary Artery Disease

Peripheral Arterial Disease: Diagnosis and Management

Omega-3 Fatty Acid Therapy: The Tide Turns for a Fish Story

Deborah J. Clegg, PhD, Michael Cody, MD, Biff F. Palmer, MD

Palliative Care and Hospice Programs

Cardiorespiratory Fitness: An Independent and Additive Marker of Risk Stratification and Health Outcomes Barry A. Franklin, PhD, Peter A. McCullough,

Effect of β-Adrenergic Blockers and Other Antihypertensive Drugs on the Risk of Melanoma Recurrence and Death—I Justin C. Moser, MD, Roxana S. Dronca,

Abraham Morgentaler, MD, Martin M

Impact of Statins on Physical Activity and Fitness: Ally or Adversary?

Sexual Activity and Chronic Heart Failure

Acupuncture Mayo Clinic Proceedings

Madonna della Pietá by Michelangelo

Quantitating the Dose of Physical Activity in Secondary Prevention: Relation of Exercise Intensity to Survival Barry A. Franklin, PhD Mayo Clinic Proceedings

Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization

Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from.

Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2 Robert N. Foley, Charles A. Herzog, Allan.

Contemporary Evidence-Based Guidelines

To B or Not to B: Is Non–High-Density Lipoprotein Cholesterol an Adequate Surrogate for Apolipoprotein B? Carl J. Lavie, MD, Richard V. Milani, MD, James.

Patient-Initiated Second Opinions: Systematic Review of Characteristics and Impact on Diagnosis, Treatment, and Satisfaction Velma L. Payne, PhD, Hardeep.

Shannon M. Dunlay, MD, MS, Naveen L. Pereira, MD, Sudhir S

On Statin Treatment to Prevent Sepsis in Dialysis Patients

Peripartum Cardiomyopathy Presenting as an Acute Myocardial Infarction

Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact Jack V. Tu, MD, PhD, Anam M. Khan,

Risks for Cardiovascular and Cardiac Deaths in Nonobese Patients With Diabetes and Coronary Heart Disease Tetsuro Tsujimoto, MD, PhD, Hiroshi Kajio,

Best Practices for Patients With Chronic Migraine

L-Carnitine in the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis James J. DiNicolantonio, PharmD, Carl J. Lavie,

Evaluation and Management of Penicillin Allergy

Leadership Models in Health Care—A Case for Servant Leadership

Adjunctive Therapies in the Treatment of Acute Coronary Syndromes

Abraham Morgentaler, MD, Martin M

Hepatocellular Carcinoma

Counseling Patients on the Use of Electronic Cigarettes

Pancreatic Tumor in a Patient With Parathyroid and Pituitary Disease

Serial Measurement of Serum Tryptase in Angiotensin-Converting Enzyme Inhibitor- Associated Angioedema Kevin R. Regner, MD, Douglas L. Riegert-Johnson,

Ross Arena, PhD, PT, FAHA, Carl J. Lavie, MD Mayo Clinic Proceedings

Serum Alkalinization and Hydrogen-Rich Water in Healthy Men

Mantle Cell Involvement of the Spleen

Preoperative Smoking Cessation: The Role of the Primary Care Provider

Brandon J. Patterson, PharmD, PhD, Debora A. Rausch, MD, Debra E

Is There an “Asymptote of Gain” Beyond Which Further Increases in Cardiorespiratory Fitness Convey No Additional Benefits on Mortality and Atrial Fibrillation?

Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization

Autonomic Tone and Benefits of Cardiac Rehabilitation Programs

Leonard A. Kaminsky, PhD, Ross Arena, PhD, Jonathan Myers, PhD

21st Century Women's Health

Managing Cancer Pain: Basic Principles and Invasive Treatments

Cindy A. Kermott, MD, MPH, Darrell R. Schroeder, MS, Stephen L

Diagnosis and Management of Headache in Older Adults

β-Blocker Use for the Stages of Heart Failure

Mayo Clinic Proceedings 2012: “A New Era in Journal Stewardship”

R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R

Cardiovascular Epidemiology and Epidemiological Modelling

Many post-MI patients are not receiving optimal therapy

Presentation transcript:

Exercise-Based Cardiac Rehabilitation and Improvements in Cardiorespiratory Fitness: Implications Regarding Patient Benefit Barry A. Franklin, PhD Mayo Clinic Proceedings Volume 88, Issue 5, Pages 431-437 (May 2013) DOI: 10.1016/j.mayocp.2013.03.009 Copyright © 2013 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure 1 Risk factor framework and the progression of cardiovascular disease, with types of prevention interventions: primordial (prevention of risk factors), primary (treatment of risk factors), and secondary (prevention of recurrent cardiovascular events). Environmental and cardiovascular health modulators include dietary and physical activity practices, cigarette smoking, pharmacotherapies (eg, aspirin, β-adrenergic blockers, statins, and angiotensin-converting enzyme inhibitors) when indicated, and coronary revascularization when appropriate. CHF = congestive heart failure; MI = myocardial infarction; PAD = peripheral arterial disease. From Circulation,3 with permission. Mayo Clinic Proceedings 2013 88, 431-437DOI: (10.1016/j.mayocp.2013.03.009) Copyright © 2013 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure 2 Impact of the amount of physical activity (kilocalories per week) on angiographic, risk factor, and weight loss outcomes associated with exercise-based cardiac rehabilitation. Mayo Clinic Proceedings 2013 88, 431-437DOI: (10.1016/j.mayocp.2013.03.009) Copyright © 2013 Mayo Foundation for Medical Education and Research Terms and Conditions